)
Visual
test
Avid Bioservices
Avid Bioservices (CDMO) investor relations material
Avid Bioservices has been acquired
Avid Bioservices Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary10 Dec, 2024
Executive summary
Revenues for Q2 FY2025 were $33.5 million, up 32% year-over-year, and $73.7 million for the six months, driven by higher manufacturing and process development revenues.
Backlog rose to $220 million at quarter-end, up 11% year-over-year, with significant revenue recognition expected over the next five quarters.
Net loss for Q2 FY2025 was $17.4 million ($0.27/share), and $22.9 million ($0.36/share) for the six months, reflecting increased SG&A and interest expenses.
On November 6, 2024, a definitive merger agreement was signed for acquisition by affiliates of GHO Capital Partners LLP and Ampersand Capital Partners, with shareholders to receive $12.50 per share in cash, a 13.8% premium to pre-announcement price.
The all-cash transaction is valued at $1.1 billion and is expected to close in Q1 2025.
Financial highlights
Q2 FY2025 revenues increased to $33.5 million from $25.4 million year-over-year; manufacturing revenues rose by $7.1 million and process development revenues by $0.9 million.
Gross loss for Q2 FY2025 was $2.0 million (negative 6% margin), improved from a $4.7 million loss (negative 18% margin) in the prior year.
SG&A expenses rose to $10.6 million, up 61% year-over-year, mainly due to higher compensation, benefits, and legal fees.
Cash and cash equivalents at October 31, 2024, were $33.4 million, down from $38.1 million at April 30, 2024.
Company’s revolving line of credit expired during the quarter.
Outlook and guidance
Management expects existing cash and anticipated operating cash flows to fund operations for at least the next 12 months.
Financial guidance is suspended due to the pending acquisition.
Significant portion of backlog expected to convert to revenue over the next five fiscal quarters.
Short-term capital expenditures for fiscal 2025 are projected at $5–$7 million.
During the merger pendency, the company is restricted from raising capital or making significant operational changes outside the ordinary course.
How will GHO/Ampersand drive Avid's growth?
What caused the increase in Q2 operating costs?
Backlog conversion timeline
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 7 FebSBIN
Q3 FY26 net profit reached ₹21,028.15 crore, driven by robust income and strategic divestments. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026. - 6 FebARI
Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy. - 6 FebSMCI
Q2 revenue jumped 123% to $12.7B, with FY26 guidance raised to at least $40B. - 6 FebRJF
Record revenues and assets, higher dividend, and acquisitions despite lower net income.
Avid Bioservices
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO) that provides specialized services for the biotechnology and biopharmaceutical industries. The company focuses on biologics, offering process development, clinical and commercial Current Good Manufacturing Practice (CGMP) manufacturing, and related services. These include bulk packaging, release and stability testing, regulatory support, upstream and downstream process optimization, analytical methods development, and cell line development. Avid supports projects from early preclinical stages to commercial-scale production. Its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage